Merck's new injectable cancer drug, Keytruda Qlex, promises to transform patient treatment with a quick administration time and flexible dosing, all while maintaining effectiveness. Available in late September, this shift is critical as the market braces for biosimilar competition.
A new review claims antidepressants don’t cause significant withdrawal effects, but new research suggests otherwise. Long-term users may face severe and debilitating symptoms after stopping. Find out the shocking reality behind antidepressant withdrawal.
Explore the often-overlooked benefits of radiation therapy as a viable option for cancer treatment. This personal account reveals the supportive environment and the human connections that can make a challenging experience more bearable.
